| scholarly article | Q13442814 |
| P50 | author | Soliman Oushy | Q49390363 |
| Michael W Graner | Q88990551 | ||
| P2093 | author name string | Mary Wang | |
| Thomas J Anchordoquy | |||
| Tessa A Harland | |||
| Justin E Hellwinkel | |||
| Dicle Gunaydin | |||
| Ger J Nguyen | |||
| P2860 | cites work | Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis | Q24307717 |
| Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers | Q24614672 | ||
| Exosomic microRNAs in the Tumor Microenvironment | Q26799945 | ||
| Tumor suppressor p53 and its gain-of-function mutants in cancer | Q27000754 | ||
| PTEN regulation of ERK1/2 signaling in cancer | Q27011088 | ||
| Astrocytes: biology and pathology | Q27490746 | ||
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| Exosomal communication goes viral | Q28083133 | ||
| What next for newly diagnosed glioblastoma? | Q28086839 | ||
| Cancer exosomes trigger fibroblast to myofibroblast differentiation | Q28299016 | ||
| Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development | Q28397739 | ||
| Exosomes from human colorectal cancer induce a tumor-like behavior in colonic mesenchymal stromal cells | Q28468628 | ||
| Medulloblastoma exosome proteomics yield functional roles for extracellular vesicles | Q28481626 | ||
| Serum-Induced Differentiation of Glioblastoma Neurospheres Leads to Enhanced Migration/Invasion Capacity That Is Associated with Increased MMP9 | Q28551757 | ||
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 | ||
| Membrane vesicles as conveyors of immune responses | Q29547765 | ||
| In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro | Q29617927 | ||
| Extracellular vesicles: exosomes, microvesicles, and friends | Q29618137 | ||
| Exosomes in Viral Disease | Q30276544 | ||
| Host matrix modulation by tumor exosomes promotes motility and invasiveness | Q30541999 | ||
| Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain. | Q30688603 | ||
| Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells | Q30908848 | ||
| Glioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2 | Q31101680 | ||
| Association of coagulation factor XIII-A with Golgi proteins within monocyte-macrophages: implications for subcellular trafficking and secretion | Q33387901 | ||
| Cancer associated fibroblasts in cancer pathogenesis | Q33664004 | ||
| Akt and c-Myc Induce Stem-Cell Markers in Mature Primary p53−/− Astrocytes and Render These Cells Gliomagenic in the Brain of Immunocompetent Mice | Q34592895 | ||
| Signaling pathways in cancer and embryonic stem cells | Q34688315 | ||
| MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development | Q35036059 | ||
| Biochemically differentiated mouse glial lines carrying a nervous system specific cell surface antigen (NS-1) | Q35079618 | ||
| Glioblastoma extracellular vesicles: reservoirs of potential biomarkers | Q35122209 | ||
| Biological properties of extracellular vesicles and their physiological functions. | Q35611763 | ||
| JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis | Q35635353 | ||
| Activation of toll-like receptor 2 promotes invasion by upregulating MMPs in glioma stem cells. | Q35663008 | ||
| Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts | Q36028740 | ||
| Look who's talking-the crosstalk between oxidative stress and autophagy supports exosomal-dependent release of HCV particles | Q36227134 | ||
| Exosomal transfer of functional small RNAs mediates cancer-stroma communication in human endometrium | Q36528364 | ||
| MMP-9 and uPAR regulated glioma cell migration | Q36542070 | ||
| Glioma-derived extracellular vesicles selectively suppress immune responses | Q36705896 | ||
| Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk | Q36736612 | ||
| Extracellular Vesicles Exploit Viral Entry Routes for Cargo Delivery. | Q36902474 | ||
| Cytokine Patterns in Brain Tumour Progression | Q36999339 | ||
| Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia. | Q37109227 | ||
| Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts. | Q37151539 | ||
| The role of regulatory T cells in malignant glioma. | Q37173953 | ||
| Radiation-induced gliomas | Q37316500 | ||
| Novel anti-angiogenic therapies for malignant gliomas | Q37325086 | ||
| MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance. | Q37331928 | ||
| Strategy for surveying the proteome using affinity proteomics and mass spectrometry | Q37398795 | ||
| Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. | Q37444920 | ||
| Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. | Q37495285 | ||
| Proteomic analyses of brain tumor cell lines amidst the unfolded protein response | Q37565293 | ||
| AHNAK enables mammary carcinoma cells to produce extracellular vesicles that increase neighboring fibroblast cell motility | Q37580353 | ||
| FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme | Q37629395 | ||
| Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment | Q37970682 | ||
| Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models | Q38037866 | ||
| Interleukins in glioblastoma pathophysiology: implications for therapy. | Q38051761 | ||
| The emerging role of exosomes in epithelial-mesenchymal-transition in cancer | Q38310370 | ||
| Regulation of the p53 response and its relationship to cancer | Q38553029 | ||
| From glioblastoma to endothelial cells through extracellular vesicles: messages for angiogenesis. | Q38736928 | ||
| Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor. | Q38769873 | ||
| Extracellular Vesicles in Brain Tumor Progression | Q38781015 | ||
| Relapsed Glioblastoma: Treatment Strategies for Initial and Subsequent Recurrences | Q38909395 | ||
| RETRACTED: SDF-1/CXCR4 Axis Regulates Cell Cycle Progression and Epithelial-Mesenchymal Transition via Up-regulation of Survivin in Glioblastoma | Q38938160 | ||
| CXCR4 Signaling Induced Epithelial-Mesenchymal Transition by PI3K/AKT and ERK Pathways in Glioblastoma | Q38946791 | ||
| The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation | Q38951799 | ||
| Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein. | Q38970131 | ||
| Cell surface protein C23 affects EGF-EGFR induced activation of ERK and PI3K-AKT pathways | Q38976208 | ||
| Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma. | Q39003387 | ||
| Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. | Q39242962 | ||
| Microenvironmental pH is a key factor for exosome traffic in tumor cells | Q39791777 | ||
| Diversity of DNA damage response of astrocytes and glioblastoma cell lines with various p53 status to treatment with etoposide and temozolomide | Q39869690 | ||
| Secretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomes | Q39938145 | ||
| BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles. | Q40126434 | ||
| Increase in both CD14-positive and CD15-positive myeloid-derived suppressor cell subpopulations in the blood of patients with glioma but predominance of CD15-positive myeloid-derived suppressor cells in glioma tissue | Q41101153 | ||
| Characterization of human thymic exosomes | Q41290239 | ||
| The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling | Q41903415 | ||
| Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy | Q42136663 | ||
| Serum exosomes and cytokines promote a T-helper cell type 2 environment in the peripheral blood of glioblastoma patients | Q42234796 | ||
| Treatment Options in Newly Diagnosed Glioblastoma | Q44532006 | ||
| Stepwise transformation of astrocytes by simian virus 40 large T antigen and epidermal growth factor receptor overexpression. | Q45768000 | ||
| Immunotherapy for high-grade glioma | Q45866091 | ||
| Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicating with human astrocytes | Q48355078 | ||
| Oligodendroglioma cells shed microvesicles which contain TRAIL as well as molecular chaperones and induce cell death in astrocytes | Q48949260 | ||
| Making a tumour's bed: glioblastoma stem cells and the vascular niche | Q51977217 | ||
| A genetically tractable model of human glioma formation. | Q52542891 | ||
| Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. | Q55466614 | ||
| Shed Membrane Vesicles and Selective Localization of Gelatinases and MMP-9/TIMP-1 Complexes | Q59348904 | ||
| P433 | issue | 1737 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phenotype | Q104053 |
| glioblastoma | Q282142 | ||
| astrocyte | Q502961 | ||
| extracellular vesicle | Q21097485 | ||
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Philosophical Transactions of the Royal Society B | Q2153239 |
| P1476 | title | Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype | |
| P478 | volume | 373 |
| Q94521453 | Breaking through the glioblastoma micro-environment via extracellular vesicles |
| Q64891768 | Exosomes derived from HBV-associated liver cancer promote chemoresistance by upregulating chaperone-mediated autophagy. |
| Q92444223 | Extracellular Vesicle-Mediated Communication between the Glioblastoma and Its Microenvironment |
| Q57798723 | Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways |
| Q89621221 | Extracellular Vesicles in Glioblastoma Tumor Microenvironment |
| Q53089902 | Extracellular vesicles in the tumour microenvironment. |
| Q58801546 | Microglia/Astrocytes-Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental Factors |
| Q91588247 | Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated Macrophages |
| Q57298233 | Primary cilium and glioblastoma |
| Q93056224 | Roles of Extracellular Vesicles in High-Grade Gliomas: Tiny Particles with Outsized Influence |
| Q91868654 | Systemic Immune Response to Traumatic CNS Injuries-Are Extracellular Vesicles the Missing Link? |
| Q88990553 | Tumor-derived exosomes, microRNAs, and cancer immune suppression |
| Q90729744 | Tumor-derived extracellular vesicles: molecular parcels that enable regulation of the immune response in cancer |
| Q98499768 | Vesiclemia: counting on extracellular vesicles for glioblastoma patients |
Search more.